Proleukin aldesleukin: Began Phase III study enrollment

Chiron Corp. (CHIR), Emeryville, Calif. Product: Proleukin aldesleukin Business: Infectious diseases Therapeutic category: Immune stimulation Target: Lymphocytes Description: Human recombinant inter...